SBDS and cancer: This idea is further supported by the report of compound heterozygous patients with the SBDS mutations N121T/R175W [30] or R175W/K62X (personal communication Akiko Shimamura, Dana Farber/Boston Children’s Cancer and Blood Disorder Center), whose only source of SBDS protein corresponds to that with the mutation R175W.